Further investigation revealed that LPS from these bacteria promoted NSCLC proliferation via the TLR4-mTOR-NF-κB-IL-6 axis, whereas rapamycin effectively inhibited the promoting effects of bacteria-derived LPS. This evidence concerns the gene IL6 and non-small cell lung carcinoma.